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Abstract
Accurate measurement of respiratory rate (RR) in neonates is challenging due to high neonatal RR variability (RRV). There is
growing evidence that RRV measurement could inform and guide neonatal care. We sought to quantify neonatal RRV during
a clinical study in which we compared multiparameter continuous physiological monitoring (MCPM) devices. Measurements
of capnography-recorded exhaled carbon dioxide across 60-s epochs were collected from neonates admitted to the neonatal
unit at Aga Khan University-Nairobi hospital. Breaths were manually counted from capnograms and using an automated
signal detection algorithm which also calculated mean and median RR for each epoch. Outcome measures were betweenand within-neonate RRV, between- and within-epoch RRV, and 95% limits of agreement, bias, and root-mean-square deviation. Twenty-seven neonates were included, with 130 epochs analysed. Mean manual breath count (MBC) was 48 breaths
per minute. Median RRV ranged from 11.5% (interquartile range (IQR) 6.8–18.9%) to 28.1% (IQR 23.5–36.7%). Bias and
limits of agreement for MBC vs algorithm-derived breath count, MBC vs algorithm-derived median breath rate, MBC vs
algorithm-derived mean breath rate were − 0.5 (− 2.7, 1.66), − 3.16 (− 12.12, 5.8), and − 3.99 (− 11.3, 3.32), respectively.
The marked RRV highlights the challenge of performing accurate RR measurements in neonates. More research is required
to optimize the use of RRV to improve care. When evaluating MCPM devices, accuracy thresholds should be less stringent
in newborns due to increased RRV. Lastly, median RR, which discounts the impact of extreme outliers, may be more reflective of the underlying physiological control of breathing.
Keywords Child health · Critical care · Delivery of health care · Diagnosis · Patient care
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Accurate measurement of respiratory rate (RR) in children
is particularly important in low-resource settings where illness and deterioration are typically diagnosed based on a
child’s clinical signs and symptoms [1–3]. To measure RR,
the World Health Organization (WHO) recommends observing and counting chest and abdominal movements over a full
60 s [4]. In practice, this recommendation is frequently modified to counting respirations over a shorter duration of time
(e.g., counting breaths for 10 s and multiplying by six). This
modification can result in up to a 50% discrepancy compared
to WHO recommendations [5]. In addition to inaccuracy,
manual breath counting can be influenced significantly by
counter bias and lacks reproducibility.
In neonates, measuring RR accurately is especially challenging given high RR and the within-neonate RR variability
(RRV) [6]. Control of breathing remains immature until after
the first month of life. Neonates often demonstrate periodic
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breathing, a benign, regular manifestation of irregular respiratory patterns, consisting of contiguous periods of alternating breaths and respiratory pauses. Healthy neonates also
may exhibit benign irregularly irregular breathing patterns
with short periods of apnea, similar to the disrupted respiratory control and ataxic breathing which is seen with opioid
administration [7, 8]. These irregular breathing patterns are
distinct from the regular rhythms of periodic breathing or
the apnea of prematurity, though there appears to be some
amount of overlap [9, 10]. In contrast to older infants and
children, neonates have a marked degree of breath-to-breath
variability and are also more likely to exhibit episodes of respiratory pause associated with stimulation and in response
to hypoxia [11]. This individual-level, within-neonate RRV,
adds to the complexity of identifying and reliably measuring true RR [12]. Perturbations, including sighs, swallows,
and coughs, can affect the duration of individual breaths,
the resulting RR, and the within-neonate RRV. Given the
high RRV in neonates, quantifying RR by observing chest
and abdominal movements as recommended by the WHO is
fraught with potential inaccuracy [13].
There will always be some level of uncertainty when
performing manual or automated measurement of RR. All
potential sources for uncertainty in RR measurement should
be considered (Table 1). The size and acceptability of the
resulting uncertainty depend on the conditions and context of the measurement. In some clinical situations, high
accuracy may not be necessary. However, in the emergency
department or intensive care unit, when it is crucial to determine if a patient has crossed a diagnostic threshold, accurate RR measurement can enable early identification and
expedited management of patient deterioration [14–17]. In
research laboratories, accuracy and precision are essential
for determining how a new device or method compares with
the reference method.
There is growing evidence which suggests including RRV
in clinical scoring systems may be beneficial for guiding
escalation and de-escalation of care [18, 19]. Heart rate variability (HRV), unlike RRV, has been extensively studied and

is commonly used as a marker of risk for mortality [20–23].
HRV is considered to be central in the clinical assessment
of diverse conditions that include neurological and sleep
disorders, muscular dystrophy, and diabetes in adults, and
sepsis in neonates [24, 25]. Like HRV, the identification of
changes in RRV could be used as an indicator of underlying
physiological disturbances [18, 19, 26].
Numerous innovative RR monitoring methods and
devices for both adults and neonates using non-contact
video, sensors embedded in bedding, motion sensors,
nanoparticles, and temperature-based methods have been
reported previously [27–31]. The variety of monitoring
methods has resulted in various different evaluation methods
and difficulty when trying to compare results across studies. A recent systematic review of RR monitoring systems
suggested standardizing validation frameworks to directly
compare different RR monitoring methods and systems [32].
Fortunately, detailed verification and validation recommendations have been made [33, 34]. If followed, these recommendations may result in future cross-comparable research
of neonatal RRV. The current research is a result of data
analyzed during systematic verification conducted within a
device comparison study.
In our study comparing neonatal multiparameter continuous physiological monitoring (MCPM) devices in Nairobi,
Kenya we sought to quantify RRV between- and withinneonates, as well as between- and within-epochs to identify
the best methods for device comparison studies. We believe
this RRV quantification will inform management of uncertainty and RRV when designing, developing, and comparing
RR monitoring devices in neonates.

2 Methods
2.1 Setting and participants
We conducted a clinical verification phase of the reference
RR monitoring device while studying low-cost neonatal

Table 1  Potential sources of uncertainty in respiratory rate measurement, approximate distribution, and potential solutions
Uncertainty

Source

Distribution

Breath-to-breath variation
Perturbation (e.g., sigh, swallow, cough)
Device uncertainty due to inaccurate timing
Device uncertainty due to missed breath(s)
Observer error due to inaccurate timing
Observer error due to missed breath(s)
Rounding error due to counting breaths in a
time interval

Neonate
Neonate
Device
Device
Observer
Observer
Analysis

Normal
Multimodal
Normal
Multimodal
Normal
Multimodal
Normal

Possible solution
Random
Non-random
Random
Non-random
Random
Non-random
Random

Extended within-neonate observation
Exclude outliers
Repeatability with multiple simultaneous devices
Repeatability with multiple simultaneous devices
Repeatability with multiple simultaneous observers
Repeatability with multiple simultaneous observers
Measure breath interval (not count)

The nature of the distributions is based on knowledge of the underlying processes and has not been validated
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Table 2  Study definitions and eligibility criteria
Study definitions
Epoch

A 60-s period of time

Breath

One cycle of neonate-initiated inhalation and exhalation (Table 3)

Breath duration

Length of time from the start to the end of a single breath

Breath start

End of a waveform trough (low point) where the carbon dioxide level starts to ascend

Respiratory rate Number of breaths initiated within an epoch
Breath rate

The number of breaths within an epoch based on the median or mean of the breath duration

Respiratory rate The dispersion of respiratory rate or breath duration (a reciprocal of the respiratory rate) within an epoch or between epochs, calculated as the standard
deviation expressed as a percentage of the mean; epochs for comparison are defined below
variability
(RRV)
Within-subject RRV

RRVbd = Breath duration variability (average within each epoch)
RRVbm = Minute-to-minute variability (average between epochs)
RRV10bd/RRV60bd = Breath duration variability between epochs measured at 10- or 60-min
intervals

Between-subject RRV

RRVbs = Between subject minute-to-minute variability

Neonatal eligibility criteria
Inclusion
criteria

∙ Male or female neonate, corrected age of < 28 days
Willingness and ability of neonate’s caregiver to provide informed consent and to be available for follow-up for the planned duration of the study

Exclusion
criteria

∙ Receiving mechanical ventilation or continuous positive airway pressure
∙ Skin abnormalities in the nasopharynx and/or oropharynx
∙ Contraindication to the application of skin sensors
∙ Known arrhythmia
∙ Any medical or psychosocial condition or circumstance that, in the opinion of the investigators, would interfere with the conduct of the study or for which
study participation might jeopardize the neonate’s health

MCPM devices in Nairobi, Kenya [35]. Study participants
were spontaneously breathing neonates admitted for observation and care in the maternity ward, neonatal intensive
care, and the neonatal high dependency units at Aga Khan
University-Nairobi (AKU-N) Hospital. Caregivers were
approached, recruited, and sequentially screened for enrollment by trained study staff during routine intake procedures.
Final eligibility determination was based on medical history, physical examination, appropriate understanding of
the study by the caregiver, and completion of the written
informed consent process (Table 2).

2.2 Study procedures and data collection
Detailed study procedures are described in the published
protocol [35]. In brief, term and preterm neonates were
enrolled in a MCPM accuracy and feasibility evaluation.
Male or female neonates were eligible if they had a corrected
age of < 28 days and the caregiver was willing and able to
provide informed consent and to be available for followup for the planned duration of the study. Neonates were
excluded if they were receiving mechanical ventilation or
continuous positive airway pressure, had skin abnormalities
in the nasopharynx and/or oropharynx or a contraindication
to the application of skin sensors, a known arrhythmia or
any medical or psychosocial condition or circumstance that,
in the opinion of the investigators, would interfere with the
conduct of the study or for which study participation might
jeopardize the neonate’s health. Solely for the purposes of
the study, we used the Masimo Rad-97 with NormoLine

capnography as a reference device to record and measure
RR using exhaled carbon dioxide (CO2) levels. The collected
continuous capnography data were digitized at approximately 20 Hz using asynchronous communication with a
custom software application. Capnography readings were
collected for a minimum of one hour and continued until the
neonate was discharged (range 1–6.25 h; median: 3.75 h).
Demographic and capnography data were entered and stored
on a secure AKU-N-hosted REDCap server [36].
Sixty-second epochs of capnography data were extracted
at predetermined time intervals and converted to capnogram
waveform tracings. Intervals between epochs were predetermined and based on study-related clinical observations: at
10-min intervals throughout the first hour of participation
followed by 60-min intervals starting at the second hour
[35]. The resulting capnogram tracings included a total of
64 s (Fig. 1); two seconds were added at the beginning and
end of each epoch to facilitate manual breath counting of
the epoch.
One of the authors (JMA, an anesthesiologist) reviewed
all capnogram tracings for quality control; difficult-to-count
plots were discarded (n = 164; Fig. 2). All remaining epochs
were included, and breaths were manually counted from capnograms and identified using an automated signal detection
algorithm. For the manual counting, capnographs were provided to two trained observers to count all breaths within
each epoch independently, and the results were averaged.
A breath was identified using a set of predefined rules created by the investigators (Table 3). If the number of breaths
counted by the two observers varied by more than three
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Fig. 1  Example capnograms (carbon dioxide (CO2) waveform plots)
before (A) and after (B) algorithm processing. The plotted CO2 waveform shows the breathing pattern of a neonate and algorithm-derived
identification of breaths (red, vertical lines). Only peaks on the white
background were included; peaks that fell within the grey zone were
ignored as they were outside the 60-s epoch. A Plotted waveform
from example epoch before processing by the algorithm. Each peak

within the 60-s epoch was counted by one to three trained observers.
The horizontal blue 15 and 20 lines were used to assist observers during irregular or incomplete breaths (not shown). B Plotted waveform
after processing by algorithm. The red vertical lines show identified
peaks, with the length and label of the red line representing the calculated breath rate based on the breath duration

breaths per epoch, a third trained observer independently
counted the plot, and the two closest counts were averaged.
The automatic breath detection method was based on a
time-domain algorithm that identified regular patterns in
physiological waveforms [37].
The algorithm was modified to identify unique breaths
in the C
 O2 signal by dividing the waveform in time and
identifying changes in direction to define segments. Specifically, an incremental-merge algorithm divided the waveform
into geometrically similar segments by establishing a line
between equidistant samples and iteratively merging adjacent lines that had the same slope sign into single, longer
lines. The resulting line segments of alternating slope signs
defined inhalation and exhalation components, as well as

artifacts interrupting this sequence. An adaptive threshold
was applied to the length of these segments to separate artifacts and double breaths from regular breathing components
[37].
The breath duration was calculated between the beginning of two adjacent regular inhalation components that
were interrupted by at least one exhalation component
and no artifact. To investigate the effect of length of time
between epochs on breath duration variability (RRVbd),
epochs were grouped into 10- and 60-min intervals for
subgroup analysis.
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Fig. 2  Recruitment flow
diagram

Table 3  Rules for identifying breaths based on graphical waveform plots
1. Count peaks (tops) of the waveform that are within the white background. Ignore peaks that are within the grey background on either side of
the image
2. A peak should be counted as a breath when the peak of the waveform is above 15 mmHg, the lower horizontal blue line
3. If the peak does not reach the lower horizontal blue line at 15 mmHg, to be counted as a breath, the peak should reach at least 50% of the
mean peak
4. The waveform should dip down to the normal baseline (either below 15 mmHg, the lower horizontal blue line, or based on other breaths). If
the waveform does not reach below this point, then this is considered part of the same (double) peak and only counted as a breath once

2.3 Data analysis
Results from the manual and automatic breath detection
methods were analyzed using STATA 13 and R [38, 39].
The coefficient of variation, the standard deviation (SD)
expressed as a percentage of the mean, was reported as
RRV between- and within-neonates, as well as betweenand within-epochs (see Table 2 for definitions).
Agreement between the manual breath counts and the
algorithm-derived breaths was assessed using the methods described by Bland and Altman’s Sect. 5.3 on replicated data pairs [40]. Agreement was reported as a mean
bias with 95% confidence intervals (CIs) and 95% limits of agreement (LOA) and root-mean-square deviation
(RMSD) [40].

2.4 Sample size
Sample size estimates for method comparison studies typically depend on the CI required around the LOA, and sample
sizes of 100 to 200 provide tight CIs [40]. We estimated that

20 neonates with ten replications each would give the 95%
CI of LOA between the first and second methods to be ± 0.76
times the SD of their differences. The study team aimed
for a sample size of at least 30 neonates to ensure a diverse
population and sufficient replications for tight CIs.

3 Results
Between June and August 2019, 35 neonates were enrolled,
and 294 clinical observations were completed. We included
130 (44.2%) CO2 waveform plots in this analysis (Fig. 2)
across 27 neonates, 23 at term (range of gestational age
32–42 weeks). Four preterm neonates, born before 37 weeks
gestation, were included. Three of the four preterm neonates
received caffeine during their admission. There were on
average 4.8 (range 2–9) epochs per subject.
The mean manual breath count was 48 breaths per minute
(bpm) (95% CI 31–71) and the median RRVbm was 25.8%
(interquartile range (IQR) 22–31.7%; Table 4; Fig. 3A).
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When grouped by neonate, the mean between-neonate manual breath count was also 48 bpm, while the median R
 RVbm
showed a narrower distribution (12.3%; IQR 9.8–19.4%).
The median between-epoch algorithm-derived R
 RVbd of
25.1% (IQR 21.1–30.8%) was marginally lower than the
median manual breath count RRVbm.
Within neonate RRV increased when observations were
taken further apart. The median R
 RV60bd was 4.6% higher
compared with the RRV10bd (28.1% (IQR 23.5–36.7%) vs
23.5% (IQR 20.5–28.5%)). A graphical representation of
the within-neonate RRV10bd and RRV60bd trends over time
showed a marked downward trend in RRV60bd between the
baseline and one-hour epochs (Fig. 3C); other time periods
did not show this trend.
Manual breath count and the algorithm-derived breath
count showed minimal bias (− 0.52) and strong agreement
(95% lower limit of agreement (LLA) − 2.7, 95% upper limit
of agreement (ULA) 1.77, RMSD 1.2; Table 5). However,
the manual breath count had a larger bias (at least − 3 bpm),
and a larger normalized spread (95% LLA 37.2% and 95%
ULA 30.4%) compared with both the algorithm-derived
median and mean breath rates and a small bias and tighter
spread of 95% LLA and 95% ULA compared with algorithm-derived breath counts (Fig. 4).
LOA were calculated based on log-transformed data
which were found to be normally distributed as evidenced
by the histogram and the Shapiro–Wilk test (S1). We also
calculated a non-parametric version of the LOA (S2), which
were the values outside which 5% of the observations fell,
based on a nonparametric approach for comparing methods
[40] which allows the use of dependent data. All these LOA
provided qualitatively similar conclusions.

4 Discussion
The results, which showed a range of RRV from 11.5 to
25.8% within 60-s epochs, were consistent with previously
published research quantifying RRV in neonates, children,
and adults, supporting the external validity of the current
data while also highlighting challenges when performing
device comparison studies [12, 33, 41–43]. This range also
suggested the RRV was within a normal range for shortterm neonatal monitoring in relatively healthy neonates; no
neonates had a deterioration of their condition during or
immediately following participation in the study.
Manually counting breaths from a capnogram is a laborintensive process commonly used in clinical RR measurement. However, due to its limited temporal precision, manual breath counting does not provide for the precise breath
durations required when estimating within-epoch mean or
median RRV, or breath rate variability. Human observers are
not precise enough to identify the exact breath duration differences required to objectively discern accurate variation.
An accurate breath identification algorithm can both identify
individual breaths and breath lengths from raw waveform
data extracted from the capnogram and can be automated.
The algorithm used in the current study showed a high level
of accuracy for the algorithm-derived breath count as compared to the manual breath count, evidenced by the small
bias, tight 95% LLA and ULAs, and a small RMSD across
all epochs, and was confirmed by plotting each breath in the
capnograms. These results suggested that this algorithm correctly identified individual breaths and could identify breath
duration and RRV. Each source of uncertainty (Table 1)

Table 4  Respiratory rate (RR) median and median coefficient of variation between- and within-neonates, as well as between- and within-epochs
Epochs
(n)

Median respiratory or
breath rate (interquartile
range)

Median respiratory or breath rate
coefficient of variation (interquartile
range)

Sub-group
Epochs at 10-min intervals

Manual count
Algorithm-derived
Manual count
Algorithm-derived
Manual count
Algorithm-derived
Manual count
Algorithm-derived

130
130
130
130
130
130
N/A
130

46.7 (43.1–52.0)
51.2 (45.1–61.8)
46.8 (42.5–55.0)
51.0 (45.1–59.3)
47.0 (39.0–56.0)
47.5 (40.0–56.0)
N/A
50 (41.4–57.1)

12.3% (9.8–19.4%)
17.6% (10.7–24.2%)
11.5% (6.8–18.9%)
17.5% (8.8–24.1%)
25.8% (22.0–31.7%)
25.1% (21.1–30.8%)
N/A
20.8% (13.6–27.3%)

Algorithm-derived (18 neonates)

63

46.1 (38–53)

Epochs at 60-min intervals

Algorithm-derived (19 neonates)

52

50.2 (38.5–60)

23.5%
(20.5–28.5%)
28.1%
(23.5–36.7%)

Between-neonates
Within-neonate
Between-epochs
Within-epoch

Sub-group analysis includes algorithm-derived RR grouped by length of time between epochs. Sub-group analysis excludes neonates with fewer
than two time-relevant epochs
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Fig. 3  Graphic representations of respiratory rate variability in all
epochs (n = 130). A Histogram showing respiratory rate variability of
all epochs. B Manual breath count for all epochs, grouped by neonate.
Within-neonate variability is identified in each individual boxplot
identifying the mean manual breath count and interquartile range.
Between-neonate variability is identified by comparing the boxplots.

C Graphical representations of the within-neonate respiratory rate
variability trends over time for epochs at 10-min and 60-min intervals. Each line represents a neonate’s trend line showing the normalized within-epoch coefficient of variation or respiratory rate variability over time across subsequent epochs

Table 5  Bland–Altman analysis results comparing manual breath count with algorithm-derived breath counts, median and mean breath rates

Manual breath count vs algorithm-derived
breath count
Manual breath count vs algorithm-derived
median breath rate
Manual breath count vs algorithm-derived
mean breath rate
Algorithm-derived breaths vs algorithmderived median breath rate

Bias (normalized) 95% Upper/lower
limits of agreement

Spread of upper and lower 95%
limits of agreement (normalized)

RMSD (normalized)

− 0.52 (− 1.1%)

− 2.7/1.66

4.37 (9.1%)

1.2 (2.5%)

− 3.16 (− 6.6%)

− 12.12/5.8

17.92 (37.2%)

5.5 (11.4%)

− 3.99 (− 8.3%)

− 11.3/3.32

14.62 (30.4%)

5.5 (11.4%)

− 2.64 (− 5.4%)

− 11.54/6.27

17.82 (36.6%)

5.2 (10.7%)

13

Journal of Clinical Monitoring and Computing

Fig. 4  Bland–Altman plots comparing manual breath count vs algorithm-derived breath count (A), manual breath count vs algorithmderived median breath rate (B), manual breath count vs algorithm-

derived mean breath rate (C), and algorithm-derived breath count vs
algorithm-derived median breath rate (D)

increased the challenge in estimating the true RR, and RRV
should be considered when comparing MCPM devices.
The marked within-epoch RRVbd that was identified
highlights the challenge of performing accurate clinical RR
measurements in neonates. Both RR and RRV will be significantly affected by the timing of the start of the epoch
analysed. RRV also needs to be reflected in typical clinical
decision-making thresholds. A longer measurement period,
for example, 60 or 120 s compared to 15 or 30 s, is likely to
make the RR more accurate due to the marked short-term,
breath-by-breath variability. It is also critical when performing device comparison studies to use the exact same breaths.
This requires a high degree of device time synchronization.
Healthy adults have mean RRs that range between 12 and
20 per minute, a 67% difference between lower and upper
‘normal’ values. Healthy neonates have a mean RR of 30 to
60 bpm, a 100% difference [41]. Some healthy neonates have
an upper RR range as high as 72 bpm [42]. The substantial

neonatal RRV identified in theses results has significant
implications for the use of guidelines, setting clinical thresholds, and when comparing RR measurement devices. The
United Nations International Children's Emergency Fund
(UNICEF) recommended a maximum RRV of no more than
two bpm in accuracy for diagnostic device comparisons of
acute respiratory infection is not appropriate for neonates
[44]. For a neonate with a RR of 70 bpm, this recommendation equates to 2.9% variability, somewhat stricter than any
of the within-neonate or between-neonate RRV identified
in our results. In an adult, a two bpm difference at ten bpm
could be an important difference (20%), but a two bpm difference in a neonate typically breathing at 60 bpm (3.3%)
would be less clinically relevant.
Furthermore, there is substantial RRV across individual
neonates over time. The algorithm-derived breath counts
identified changes in neonatal R
 RV10bd and RRV60bd and
across all epochs. RRV was higher within RRV60bd epochs
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compared with R
 RV 10bd. Previous research looking at
pediatric populations has suggested RRV could be used to
diagnose sleep apnea–hypopnea syndrome [19]. In adults,
within-subject RRV might be useful as a predictor of subsequent intensive care unit admission [18]. In neonates, RRV
may be used to improve clinical care, but more research is
needed.
A common dilemma encountered when performing studies of RR measurement is the definition of a ‘true’ breath
[45]. Various methods have been used to estimate RR across
devices that result in the measurement of different respiratory events as breaths. Small ineffectual respiratory efforts
are commonly seen in neonates and may not be consistently
accepted or rejected as breaths. Capnograms show many
different patterns, including small-amplitude ineffective
breaths, double breaths (two peaks in a single breath), subsequent breaths starting before the waveform reaches the
trough or baseline value, pauses, catch-up rapid breathing,
sighs, and sharp rapid cycles as seen with coughs (Fig. 1;
Table 3). Further investigation into the identification and
inclusion of abnormal respiratory events during respiratory
device accuracy comparison studies are needed.
The clinical implication of this high degree of RRV, even
in neonates with regular breathing, is that clinicians should
be aware of the inherent uncertainty of clinical decisions
made based on selected threshold values. It would be advisable to use repeated observations before making critical
clinical decisions and ideally to use continuous monitoring
devices and values summarized over more than one minute.
When conducting device comparison studies, accuracy
thresholds should be adapted to a neonate’s baseline RR.
Therefore, we suggest that an accuracy threshold should be
normalized as a percentage of the baseline value and not
more restrictive than the within-neonate RRV. This aligns
with a previous proposal to use a percentage error threshold
for LOA to determine the acceptability of a new technique
in cardiac measurement and is also relevant when comparing RR measurement technologies [46]. When conducting
RR accuracy testing, precise synchronization between investigational and reference devices will ensure that the same
breaths are compared between devices. Measuring RR in a
calm child, as recommended by WHO, will also minimize
variability. However, following the WHO recommendations for RR measurement results in a rounding-down to
the nearest breath and assumes the mean breathing rate is
the most important clinical variable [47]. Instead, a median
RR, unaffected by cough or pause, may be more reflective of
the underlying physiological control of breathing and more
clinically relevant than a mean breath count over 60 s.
We did not study the full range of RRV in real-world
settings, particularly among critically ill neonates. The
RRV identified in our study likely under-represents the true
RRV present in neonates given the data selection used only

capnograms with easy-to-identify breaths in the manual
breath count and algorithm-derived breath count processes.
Epochs that were excluded from analysis were not evenly
distributed across neonates and poor data quality was the
most common reason for exclusion. Selecting good quality
capnograms likely increased the observed agreement within
the Bland–Altman analysis. Expansion of the data quality
thresholds for data inclusion would likely result in wider
CIs and increased RRV.
The capnogram CO2 sampling rate was approximately
20 times per second or 20 Hz which is likely sufficient for
an adult breathing at 10 to 20 breaths per minute. However,
sampling frequency inaccuracies are more apparent at higher
breath rates, such as those seen in distressed neonates (which
may exceed 80 breaths per minute). When working with neonates or other populations expected to have high breath rates,
sampling rates of 100 Hz, and even as high as > 200 Hz, are
suggested [48]. These higher sampling rates would avoid
any aliasing effects, enable oversampling to accommodate
filtering to remove artifacts, and ensure precision in RRVbd
estimation.
In the current study, the resulting algorithm-derived
breath count had closer agreement with the manual breath
count than either the algorithm-derived mean or median
breath rates. This finding highlights the impact that smoothing, averaging, normalizing, or other post-processing procedures may have on RR measurement. Most devices will
provide a processed result rather than a count, so consideration as to the impact these post-processing decisions are
critically important when evaluating automated devices.
The critical question that remains as yet unresolved, is the
clinical importance of count or the mean/median as a representation of disease severity? RR is often averaged across
multiple breaths, resulting in additional uncertainty when
making clinical decisions and when comparing devices.
These results identify the range and sources of RRV
found between- and within-neonates, as well as betweenand within-epochs. RR is traditionally measured by counting
the number of breaths within 60 s. While manual counting
may seem to be a practical clinical approach, it has limitations, especially when compared to RR measurement with
digital devices. Large within-neonate RRV will also impact
the application of RR thresholds in MCPM devices and their
clinical applications. For devices that estimate RR, we propose a median value of inter-breath intervals within 60 s to
remove any extreme outliers and to minimize the effect of
rounding.
Supplementary Information The online version contains supplementary material available at https://d oi.o rg/1 0.1 007/s 10877-0 22-0 0840-2.
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